DRTX Related Company Press Releases

May 16, 2013 01:44 PM Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors

May 9, 2013 07:00 AM Durata Therapeutics, Inc. Reports First Quarter 2013 Financial Results

May 7, 2013 07:30 AM Durata Therapeutics to Present at Bank of America Merrill Lynch 2013 Healthcare Conference

May 2, 2013 07:30 AM Durata Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013

May 2, 2013 06:00 AM Sofinnova Ventures Announces Team Expansion and Promotion

Apr 29, 2013 07:30 AM New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting

Apr 29, 2013 07:30 AM Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting

Apr 24, 2013 07:30 AM Durata Therapeutics to Present Two Dalbavancin Posters at the 23rd Annual ECCMID Meeting

Apr 22, 2013 03:30 PM Durata Therapeutics to Present at the 2013 Needham Healthcare Conference

Apr 17, 2013 04:15 PM Durata Therapeutics Closes Public Offering of Common Stock

Apr 12, 2013 07:30 AM Durata Therapeutics Prices Public Offering of Common Stock

Apr 2, 2013 03:30 PM Durata Therapeutics to Host Reimbursement Seminar on April 23, 2013